Immunic IMUX
NASDAQ IMUX
$8.12 +0.08 (+1.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Immunic (IMUX) Other Non-Current Liabilities (2013 - 2019)

Updated

Analysis

Immunic (IMUX) Other Non-Current Liabilities (2013 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Immunic 341.81 Mn -50.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 41,000.00
Jun 30, 2019 41,000.00
Dec 31, 2015 101,000.00
Sep 30, 2015 146,000.00
Jun 30, 2015 159,000.00
Mar 31, 2015 200,000.00
Dec 31, 2014 241,000.00
Sep 30, 2014 283,000.00
Jun 30, 2014 292,000.00
Mar 31, 2014 279,000.00
Dec 31, 2013 321,000.00
API Access

Immunic Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IMUX&period=max&api_key=YOUR_API_KEY